ChartMill assigns a Buy % Consensus number of 78% to MIST. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-11 | Wells Fargo | Initiate | Overweight |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-22 | Rodman & Renshaw | Initiate | Buy |
| 2024-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-27 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-20 | Jefferies | Downgrade | Buy -> Hold |
| 2023-05-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-12 | Oppenheimer | Maintains | Outperform |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-14 | HC Wainwright & Co. | Maintains | Buy |
| 2022-04-22 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-03-05 | HC Wainwright & Co. | Initiate | Buy |
11 analysts have analysed MIST and the average price target is 3.83 USD. This implies a price increase of 42.72% is expected in the next year compared to the current price of 2.68.
The consensus rating for MILESTONE PHARMACEUTICALS IN (MIST) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.